BD Announces $24 Million U.S. Government Investment to Support Scale Up of U.S. Manufacturing of COVID-19 Diagnostic Tests

Capital investments will enable U.S. manufacturing of 8 million BD Veritor™ brand SARS-CoV-2 tests per month

COVID-19 | Cardinal Health Global Preparedness

During the COVID-19 pandemic, we are working around the clock to meet the needs of healthcare providers so they can safely serve the patients who depend on them.

Crisis Preparedness and Management as a Competitive Advantage

Beutlich® Pharmaceuticals, LLC has been offering healthcare professionals unique solutions for pain management and preventative care since 1954.

We are a family-owned business whose integrity our customers can count on. We will never cut corners to save money; we will give the best product to our customers in all situations. Our name on the label assures that quality.

DSX® 4-Plate ELISA Processing System

Pioneering Microplate Technology for more than 50 Years

Predictive models could save lives in rampant opioid crisis

Before Northeastern professor James Benneyan described his research, he gave a stark reminder of the opioid epidemic it aims to address.

Pre-clinical study suggests path toward non-addictive painkillers

A pre-clinical study led by Indiana University scientists reports a promising step forward in the search for pain relief methods without the addictive side effects behind the country's current opioid addiction crisis.

Taking four or more prescription meds? Consider scaling back

(HealthDay)—More than half of Americans regularly take about four prescription medications, increasing the likelihood that mistakes could occur, according to Consumer Reports.

AstraZeneca wins US approval for lymphoma drug

U.S. regulators have approved a new treatment for people with a rare form of non-Hodgkin lymphoma.